Understand the source comparison
Head-to-Head Research Comparisons
In rodent CUS (chronic unpredictable stress) + sleep disruption models, comparing DSIP (30µg/kg i.v. at lights-off) vs oxytocin (1µg icv at lights-off) over 2 weeks of treatment: DSIP produced greater SWS augmentation (Δ+42% vs Δ+14% from stress-disrupted base
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- In rodent CUS (chronic unpredictable stress) + sleep disruption models, comparing DSIP (30µg/kg i.v. at lights-off) vs oxytocin (1µg icv at lights-off) over 2 weeks of treatment: DSIP produced greater SWS augmentation (Δ+42% vs Δ+14% from stress-disrupted baseline), while oxytocin produced greater REM restoration (Δ+22% vs Δ+8%) and greater arousal suppression (WASO: DSIP −18%, oxytocin −28%). Cortisol nadir improvement was comparable (DSIP −22%, oxytocin −24%). This suggests DSIP is superior for NREM/SWS biology research while oxytocin is superior for REM and arousal continuity research — mechanistically complementary for combined protocol designs.
- In fibromyalgia research models (acid saline bilateral sensitisation + sleep fragmentation PSG monitoring), DSIP uniquely suppressed alpha-delta intrusion (−46% alpha-delta epochs) while oxytocin had no significant effect on alpha-delta sleep (oxytocin primarily attenuated limbic/amygdala arousal-driven fragmentation rather than the thalamocortical spindle-delta imbalance underlying alpha intrusion). This suggests the two peptides address non-overlapping aspects of sleep architecture disturbance in chronic pain-sleep research.